PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy (vol 128, pg 1413, 2018)

被引：24

作者：

Zamarin, Dmitriy

Ricca, Jacob M.

Sadekova, Svetlana

Oseledchyk, Anton

Yu, Ying

Blumenschein, Wendy M.

Wong, Jerelyn

Gigoux, Mathieu

Merghoub, Taha

Wolchok, Jedd D. ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
,11
,12
,13
,14
,15
,16
,17
,18
,19
,20
,21
,22
,23
,24
,25
,26
,27
]}

机构：

[1] Adapt Biotechnol, Seattle, WA USA

[2] Advaxis, Princeton, NJ USA

[3] Amgen Inc, Thousand Oaks, CA USA

[4] Array BioPharma, Boulder, CO USA

[5] Ascentage Pharma, Rockville, MD USA

[6] BeiGene, Hong Kong, Hong Kong, Peoples R China

[7] Bristol Myers Squibb, New York, NY USA

[8] Celgene, Summit, NJ USA

[9] Chugai Pharmaceut Co Ltd, Tokyo, Japan

[10] Eli Lilly & Co, Indianapolis, IN 46285 USA

[11] F Star, Cambridge, England

[12] Genentech Inc, San Francisco, CA USA

[13] Kleo Pharmaceut, New Haven, CT USA

[14] MedImmune, Gaithersburg, MD USA

[15] Merck, Kenilworth, NJ USA

[16] Neon Therapuet, Cambridge, MA USA

[17] Ono Pharmaceut Co, Osaka, Japan

[18] Polaris Pharma, San Diego, CA USA

[19] Polynoma, San Diego, CA USA

[20] PsiOxus Therapeut, Abingdon, Oxon, England

[21] PureTech Hlth, Boston, MA USA

[22] Recepta Biopharma SA, Sao Paulo, Brazil

[23] Trieza Therapeut, Cambridge, MA USA

[24] Sellas Life Sci, New York, NY USA

[25] Serametrix Immune Monitoring, Carlsbad, CA USA

[26] Surface Oncol, Cambridge, MA USA

[27] Syndax, Waltham, MA USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 128卷 / 11期

关键词：

D O I：

10.1172/JCI125039

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：5184 / 5184

页数：1

共 50 条

[1] PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Zamarin, Dmitriy
Ricca, Jacob M.
Sadekova, Svetlana
Oseledchyk, Anton
Yu, Ying
Blumenschein, Wendy M.
Wong, Jerelyn
Gigoux, Mathieu
Merghoub, Taha
Wolchok, Jedd D.
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1413 - 1428
[2] Upregulation of PD-L1 in tumor microenvironment is a resistance mechanism for oncolytic virus immunotherapy
Zamarin, Dmitriy
Ricca, Jacob
Oseledchyk, Anton
Gigoux, Mathieu
Merghoub, Taha
Wolchok, Jedd
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[3] Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression (vol 128, pg 805, 2018)
Lin, Heng
Wei, Shuang
Hurt, Elaine M.
Green, Michael D.
Zhao, Lili
Vatan, Linda
Szeliga, Wojciech
Herbst, Ronald
Harms, Paul W.
Fecher, Leslie A.
Vats, Pankaj
Chinnaiyan, Arul M.
Lao, Christopher D.
Lawrence, Theodore S.
Wicha, Max
Hamanishi, Junzo
Mandai, Masaki
Kryczek, Ilona
Zou, Weiping
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1708 - 1708
[4] Role of tumor microenvironment in the regulation of PD-L1: A novel role in resistance to cancer immunotherapy
Khandani, Nirvana
Ghahremanloo, Atefeh
Hashemy, Seyed Isaac
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (10) : 6496 - 6506
[5] How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC
Chen, Li
Jiang, Xiaoying
Li, Yuanheng
Zhang, Qiqi
Li, Qing
Zhang, Xiaoyan
Zhang, Meng
Yu, Qiongfang
Gao, Dian
CLINICAL IMMUNOLOGY, 2022, 237
[6] Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade (vol 29, pg 285, 2016)
Tang, Haidong
Wang, Yang
Chlewicki, Lukasz K.
Zhang, Yuan
Guo, Jingya
Liang, Wei
Wang, Jieyi
Wang, Xiaoxiao
Fu, Yang-Xin
CANCER CELL, 2016, 30 (03) : 500 - 500
[7] Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
Yan, Huiyu
Jiang, Aimin
Huang, Yinong
Zhang, Jun
Yang, Wenguang
Zhang, Wei
Liu, Tianya
FRONTIERS IN IMMUNOLOGY, 2023, 14
[8] Regulation of PD-L1 expression in the tumor microenvironment
Yi, Ming
Niu, Mengke
Xu, Linping
Luo, Suxia
Wu, Kongming
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[9] Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi
Mengke Niu
Linping Xu
Suxia Luo
Kongming Wu
Journal of Hematology & Oncology, 14
[10] Altering the tumor microenvironment to improve immunotherapy: Molecular imaging of PD-L1 in pancreatic cancer
Henry, Kelly
Davydova, Maria
Dilling, Thomas
Fox, Ian
Lewis, Jason
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258

← 1 2 3 4 5 →